The Global Trial Steering Committee (TSC) holds the primary role of providing overall supervision and management of the trial. They are responsible for the design, protocol, development, conduct, data collection and interpretation and dissemination of results. The TSC are the decision-making body responsible for implementing changes to the protocol, including the addition of new domains or interventions, and those amendments necessitating from recommendations from the trial’s Independent Data Monitoring Committee (IDMC).
The TSC will review trial progress and set policies relating to trial conduct, secondary analysis, data management and presentation of results. It, and its members, may also assist in trial site education for investigators and staff, as needed.
Global Trial Steering Committee Members
Prof Meg Jardine (Chair)
Chief Investigator
A/Prof Rathika Krishnasamy
Platform Co-Director and Australia Lead
Dr Brendan Smyth
Platform Co-Director
Dr Smeeta Sinha
United Kingdom Lead
Dr Janak de Zoysa
New Zealand Lead
Mr Arlen Wilcox
Global Project Manager
Dr Tamara Young
Clinical Trial Fellow
Prof Grahame Elder
Investigator
Prof Carmel Hawley
Investigator
A/Prof Nigel Toussaint
Investigator